JAMA Author Interviews podcast

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis

0:00
9:57
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women’s Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.

Related Content:

Altri episodi di "JAMA Author Interviews"